RARA CRAFT DATABASE for FDA Medical Devices
510(k)K252117

FDA DEVICE FACTS

Biodegradable Powder Free Nitrile Examination Glove, Blue Color, Tested for use with Chemotherapy drugs, Fentanyl Citrate, Simulated Gastric Acid and Fentanyl Citrate-Simulated Gastric Acid Solution

Sw Technologies, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJune 24, 2026PRODUCT CODELZACLINICAL AREAPatient Monitoring

Indications for use

A disposable device intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner. Chemotherapy Drug and Concentration — Breakthrough times in minutes per ASTM D6978-05 (2019):

- Carmustine (BCNU), 3.3 mg/ml — 86.3

- Cisplatin, 1.0 mg/ml — >240

- Cyclophosphamide (Cytoxan), 20 mg/ml — >240

- Dacarbazine (DTIC), 10 mg/ml — >240

- Doxorubicin Hydrochloride, 2.0 mg/ml — >240

- Etoposide (Toposar), 20 mg/ml — >240

- Fluorouracil, 50 mg/ml — >240

- Paclitaxel (Taxol), 6.0 mg/ml — >240

- Thiotepa, 10 mg/ml — 89.3

- Bleomycin Sulfate, 15 mg/ml (15,000 ppm) — >240

- Busulfan, 6 mg/ml (6,000 ppm) — >240

- Carboplatin, 10 mg/ml (10,000 ppm) — >240

- Cytarabine, 100 mg/ml (100,000 ppm) — >240

- Daunorubicin HCl, 5 mg/ml (5,000 ppm) — >240

- Docetaxel HCl, 10 mg/ml (10,000 ppm) — >240

- Epirubicin HCl (Ellence), 2 mg/ml (2,000 ppm) — >240

- Fludarabine Phosphate, 25 mg/ml (25,000 ppm) — >240

- Gemcitabine HCl, 38 mg/ml (38,000 ppm) — >240

- Idarubicin HCl, 1 mg/ml (1,000 ppm) — >240

- Mechlorethamine HCl, 1 mg/ml (1,000 ppm) — >240

- Melphalan HCl, 5 mg/ml (5,000 ppm) — >240

- Methotrexate, 25 mg/ml (25,000 ppm) — >240

- Mitomycin C, 0.5 mg/ml (500 ppm) — >240

- Mitoxantrone HCl, 2 mg/ml (2,000 ppm) — >240

- Oxaliplatin, 2 mg/ml (2,000 ppm) — >240

- Rituximab, 10 mg/ml (10,000 ppm) — >240

- Trisenox (Arsenic Trioxide), 1 mg/ml (1,000 ppm) — >240

- Vincristine Sulfate, 1 mg/ml (1,000 ppm) — >240

- Vinorelbine, 10 mg/ml (10,000 ppm) — >240

- Ifosfamide (50.0 mg/ml) — >240

- Irinotecan (20.0 mg/ml) — >240

- Fentanyl Citrate 100 mcg/2 ml — >240

- Simulated Gastric Acid — >240

- Fentanyl-Simulated Gastric Acid Solution 50/50 — >240 Caution: Please note low permeation times for Carmustine at 86.3 minutes and Thiotepa at 89.3 minutes.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: July 28, 2026